Uterine Fibroids Global Clinical Trials Review, H2, 2012
Summary
GlobalData's clinical trial report, "Uterine Fibroids Global Clinical Trials Review, H2, 2012" provides data on the Uterine Fibroids clinical trial scenario. This report provides elemental information and data relating to the clinical trials on Uterine Fibroids. It includes an overview of the trial numbers and their recruitment status as per the site of trial conduction across the globe. The databook offers a preliminary coverage of disease clinical trials by their phase, trial status, prominence of the sponsors and also provides briefing pertaining to the number of trials for the key drugs for treating Uterine Fibroids. This report is built using data and information sourced from proprietary databases, primary and secondary research and in-house analysis by GlobalData's team of industry experts.
Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.
Scope
Data on the number of clinical trials conducted in North America, South and Central America, Europe, Middle-East and Africa and Asia-pacific and top five national contributions in each, along with the clinical trial scenario in BRIC nations
Clinical trial (complete and in progress) data by phase, trial status, subjects recruited and sponsor type
Listings of discontinued trials (suspended, withdrawn and terminated)
Reasons to buy
Understand the dynamics of a particular indication in a condensed manner
Abridged view of the performance of the trials in terms of their status, recruitment, location, sponsor type and many more
Obtain discontinued trial listing for trials across the globe
Espy the commercial landscape of the major Universities / Institutes / Hospitals or Companies
Keywords
Uterine Fibroids Clinical Trials, Trial Designs, Subjects Recruited, Unaccomplished Trials of Uterine Fibroids, Pfizer, AstraZeneca, Novartis, GlaxoSmithKline, Sanofi, Eli Lilly and Company, Johnson & Johnson, Merck & Co., Inc, Bristol-Myers Squibb Company, Abbott Laboratories, Hoffmann-La Roche Ltd., Celgene Corporation, Daiichi Sankyo Company, Ltd., Bayer AG, Eisai Inc., GE Healthcare, Biogen Idec Inc., Copharos Inc., Wyeth Pharmaceuticals Inc., National Cancer Center, The University of Texas, M.D. Andersons, Vanderbilt Medical Center, Memorial Sloan Kettering Cancer Center, Cancer Research UK, North Central Cancer Group, Robert H. Lurie Comprehensive Cancer Center of Northwestern University, Fred Hutchinson Cancer Research Center, European Organization for Research and Treatment of Cancer, Dana-Farber Cancer Institute, The Cancer and Leukemia Group B, Columbia University, UCLA's Jonsson Comprehensive Cancer Center, Case Comprehensive Cancer Center, Mayo Clinic, Duke University, Ohio State University, National Cancer Center, University of Pennsylvania.
Table of Contents
TOC
Table of Contents
Table of Contents 2
List of Tables 4
List of Figures 6
Introduction 7
Uterine Fibroids 7
Report Guidance 7
Clinical Trials by Region 8
Clinical Trials by Country 9
Top Five Countries Contributing to Clinical Trials in Asia-Pacific 11
Top Five Countries Contributing to Clinical Trials in Europe 12
Top Countries Contributing to Clinical Trials in North America 13
Top Countries Contributing to Clinical Trials in Middle East and Africa 14
Top Countries Contributing to Clinical Trials in Central and South America 15
Clinical Trials by BRIC Nations 16
Clinical Trials by G7 Nations 17
Clinical Trials in G7 Nations by Trial Status 18
Clinical Trials by E7 Nations 19
Clinical Trials in E7 Nations by Trial Status 20
Clinical Trials by Phase 21
In Progress Trials by Phase 22
Clinical Trials by Trial Status 23
Unaccomplished Trials of Uterine Fibroids 24
Subjects Recruited Over a Period of Time 27
Prominent Sponsors 28
Top Companies Participating in Uterine Fibroids Therapeutics Clinical Trials 30
Prominent Drug Comparison 32
Clinical Trial Profiles 33
Clinical Trial Overview of Top Companies 33
Repros Therapeutics Inc. 33
Clinical Trial Overview of Repros Therapeutics Inc. 33
Abbott Laboratories 35
Clinical Trial Overview of Abbott Laboratories 35
PregLem SA 36
Clinical Trial Overview of PregLem SA 36
Pfizer Inc. 37
Clinical Trial Overview of Pfizer Inc. 37
Takeda Pharmaceutical Company Limited 38
Clinical Trial Overview of Takeda Pharmaceutical Company Limited 38
Mediterranea Medica S.L. 39
Clinical Trial Overview of Mediterranea Medica S.L. 39
GAAD Medical Research Institute Inc 40
Clinical Trial Overview of GAAD Medical Research Institute Inc 40
Laboratorios Litaphar, S.A. 41
Clinical Trial Overview of Laboratorios Litaphar, S.A. 41
BioPro Pharmaceutical, Inc. 42
Clinical Trial Overview of BioPro Pharmaceutical, Inc. 42
HRA Pharma, SA 43
Clinical Trial Overview of HRA Pharma, SA 43
Halt Medical, Inc. 44
Clinical Trial Overview of Halt Medical, Inc. 44
Bayer AG 45
Clinical Trial Overview of Bayer AG 45
GlaxoSmithKline plc 46
Clinical Trial Overview of GlaxoSmithKline plc 46
Clinical Trial Overview of Top Universities / Institutes / Hospitals 47
Ullevaal University Hospital 47
Clinical Trial Overview of Ullevaal University Hospital 47
Imperial College London 48
Clinical Trial Overview of Imperial College London 48
Taipei Veterans General Hospital 49
Clinical Trial Overview of Taipei Veterans General Hospital 49
Mayo Clinic 50
Clinical Trial Overview of Mayo Clinic 50
Huazhong University of Science & Technology 51
Clinical Trial Overview of Huazhong University of Science & Technology 51
Poitiers University Hospital 52
Clinical Trial Overview of Poitiers University Hospital 52
Mount Sinai School of Medicine 53
Clinical Trial Overview of Mount Sinai School of Medicine 53
University of Manitoba 54
Clinical Trial Overview of University of Manitoba 54
The Cleveland Clinic 55
Clinical Trial Overview of The Cleveland Clinic 55
Seoul National University Hospital 56
Clinical Trial Overview of Seoul National University Hospital 56
University of Sao Paulo 57
Clinical Trial Overview of University of Sao Paulo 57
Northwestern University 58
Clinical Trial Overview of Northwestern University 58
Catholic University of the Sacred Heart 59
Clinical Trial Overview of Catholic University of the Sacred Heart 59
Sun Yat-sen University 60
Clinical Trial Overview of Sun Yat-sen University 60
National Taiwan University Hospital 61
Clinical Trial Overview of National Taiwan University Hospital 61
Bayside Health 62
Clinical Trial Overview of Bayside Health 62
Sunnybrook Health Sciences Centre 63
Clinical Trial Overview of Sunnybrook Health Sciences Centre 63
Karolinska Institutet 64
Clinical Trial Overview of Karolinska Institutet 64
Chinese University of Hong Kong 65
Clinical Trial Overview of Chinese University of Hong Kong 65
University of California, Davis 66
Clinical Trial Overview of University of California, Davis 66
Uterine Fibroids Global Clinical Trials Review, H2, 2012 published by GlobalData in July 24, 2012. This report consists of Pages: 103 and the price starts from US $ 2500.
The contents of this page may be different from the latest version. Please contact us for details.
